Abbott stock rose Wednesday after the health care giant narrowly beat Wall Street's third-quarter expectations and raised the midpoint of its earnings outlook. Please watch the video at Investors ...

Stryker Corporation's growth strategy includes acquisitions, but high debt levels and goodwill present challenges, making ...

The agreement will dismiss all pending cases in courts and patent offices worldwide, along with a provision preventing legal ...

Abbott Laboratories is rated a Buy due to growth indicators, diversified portfolio, strong profit margin. Read an investment ...

Abbott has announced it has reached an agreement with DexCom, Inc. to settle all outstanding patent disputes between the ...

US medical device company Abbott has said it plans to launch a new range of 'biowearable' health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring.

Abbott Laboratories engages in the discovery ... Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded ...

Medical device company Abbott is opening a new manufacturing facility producing diabetes technology in Kilkenny which is set to employ more than 800 people, while another 200 jobs will be created at ...

Global Medical Devices Market Predicted to Reach $1.30 Trillion by 2029 Amid Rising Technological Advancements Medical ...

Now, medical device companies, including Abbott Laboratories, are hoping health enthusiasts will embrace a new type of wellness accessory: wearable sensors to track glucose levels. Unlike previous ...

The latest trading session saw Abbott (ABT) ending at $118.77 ... Coming into today, shares of the maker of infant formula, medical devices and drugs had gained 4.92% in the past month.